Roche Holding AG (OTC:RHHBY) is reportedly contemplating the divestiture of Flatiron Health, a cancer data specialist Roche acquired in 2018 for $1.9 billion. The move underscores the complexities and potential pitfalls that large pharmaceutical companies encounter when investing in early-stage health technology firms. Also Read: Roche’s New Immunotherapy Fails To Show Benefit Over Merck’s Blockbuster Keytruda In Lung Cancer Patients. Flatiron Health was founded by two former executives from Alphabet Inc’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google. The company manages electronic patient records for numerous U.S. cancer clinics, boasting one of the most extensive repositories of cancer data. The start-up mines this data and sells it to ...